Eye2Gene
London, United Kingdom
Eye2Gene, a UCL/Moorfield Eye Hospital spinout, is the first AI-powered precision ophthalmology platform integrating multimodal retinal imaging and genetics to accelerate clinical trials, initially for Inherited Retinal Diseases(IRD). Our software helps pharma partners identify genetically stratified cohorts, cut screen failures, and replace slow, costly manual image analysis with automated quantitative imaging biomarkers delivered in seconds, speeding trial execution and monitoring.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2026
- Website
- www.eye2gene.com
Only accessible to MedStartr community members.
Join nowWhat do you think of Eye2Gene?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now